() Neil Davidson talks to Proactive London about their 'busy year' which includes global manufacturing deals in Singapore and Australia.
Davidson says they've gone from just being a 'a good idea' in regards to tackling some of the major issues in regards to public health, with obesity and cholesterol control to now aiming for profitability by the end of 2020, Davidson is confident 'the business is moving in the right direction'.
With 'massive sales' in the prebiotics division and 'exceptional sales' in probiotics areas - Davidson is certain these two areas will keep boosting the company forwards thanks to their first generation products and their plans to strategise second generation products in 2021.
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of OptiBiotix Health PLC named herein, including the promotion by the Company of OptiBiotix Health PLC in any Content on the Site, the Company...
FOR OUR FULL DISCLAIMER CLICK HERE